(AKE) Arkema - Ratings and Ratios
Exchange: PA • Country: France • Currency: EUR • Type: Common Stock • ISIN: FR0010313833
AKE: Adhesives, Coatings, Sealants, Polymers, Additives
Arkema S.A., a global leader in specialty materials, operates across Europe, the Americas, Asia, and internationally. The company is structured into three main segments: Adhesive Solutions, Advanced Materials and Coating Solutions, and Intermediates. The Adhesive Solutions segment offers a diverse range of products, including sealants, flooring adhesives, and waterproofing systems, catering to construction, automotive, and packaging industries. It also provides high-performance polymers such as polyamides and fluorospecialties, along with additives like surfactants and peroxides. The Advanced Materials and Coating Solutions segment specializes in acrylics, photocure resins, and rheology additives, serving markets like electronics, 3D printing, and water treatment. The Intermediates segment produces fluorogases and acrylics, used in applications such as refrigeration and oil extraction. Established in 2003, Arkema is headquartered in Colombes, France, and is recognized for its innovative chemical solutions.
Based on the provided data, Arkemas stock (Ticker: AKE) is trading at €66.00 with a market cap of €4,634.94M. The P/E ratio of 13.66 indicates moderate valuation, while the forward P/E of 7.76 suggests potential undervaluation. The price-to-book ratio of 0.62 reflects a discount relative to its book value. The average 20-day volume is 235,875 shares, with a last price of €66.00. The SMA-20, SMA-50, and SMA-200 are €64.93, €74.19, and €77.83, respectively, indicating a recent downward trend. The ATR of 2.93 suggests moderate volatility.
Additional Sources for AKE Stock
AKE Stock Overview
Market Cap in USD | 5,694m |
Sector | Basic Materials |
Industry | Specialty Chemicals |
GiC Sub-Industry | Diversified Chemicals |
IPO / Inception |
AKE Stock Ratings
Growth Rating | -19.4 |
Fundamental | -1.25 |
Dividend Rating | 92.6 |
Rel. Strength | -27.2 |
Analysts | - |
Fair Price Momentum | 65.12 EUR |
Fair Price DCF | 97.13 EUR |
AKE Dividends
Dividend Yield 12m | 9.75% |
Yield on Cost 5y | 11.03% |
Annual Growth 5y | 9.73% |
Payout Consistency | 97.2% |
AKE Growth Ratios
Growth Correlation 3m | -80.8% |
Growth Correlation 12m | -74.4% |
Growth Correlation 5y | -16.3% |
CAGR 5y | 0.37% |
CAGR/Max DD 5y | 0.01 |
Sharpe Ratio 12m | -0.63 |
Alpha | -39.15 |
Beta | 0.589 |
Volatility | 39.26% |
Current Volume | 223.9k |
Average Volume 20d | 208.3k |
As of May 10, 2025, the stock is trading at EUR 65.60 with a total of 223,867 shares traded.
Over the past week, the price has changed by -1.94%, over one month by +5.13%, over three months by -17.79% and over the past year by -30.98%.
Neither. Based on ValueRay Fundamental Analyses, Arkema is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -1.25 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AKE as of May 2025 is 65.12. This means that AKE is currently overvalued and has a potential downside of -0.73%.
Arkema has no consensus analysts rating.
According to ValueRays Forecast Model, AKE Arkema will be worth about 70.3 in May 2026. The stock is currently trading at 65.60. This means that the stock has a potential upside of +7.21%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 93.2 | 42% |
Analysts Target Price | - | - |
ValueRay Target Price | 70.3 | 7.2% |